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Background: Adherence to the Mediterranean diet (MD) is associated with a reduced risk of several cancers. However, studies
conducted in Mediterranean regions are scanty.
Methods: To investigate the relation between MD and colorectal cancer risk in Italy, we pooled data from three case–control
studies, including a total of 3745 colorectal cancer cases and 6804 hospital controls. Adherence to the MD was assessed using an a
priori Mediterranean Diet Score (MDS), based on nine components.
Results: Compared with the lowest adherence to the MD (0–2 MDS), the odds ratio (OR) was 0.52 (95% confidence interval (CI)
0.43–0.62) for the highest adherence (7–9 MDS), with a significant inverse trend in risk (Po0.0001). The OR for a 1-point increment
in the MDS was 0.89 (95% CI 0.86–0.91). The inverse association was consistent across studies, cancer anatomical subsites and
strata of selected covariates.
Conclusions: This Italian study confirms a favourable role of MD on colorectal cancer risk.
The role of single foods and nutrients in colorectal carcinogenesis
is well documented (World Cancer Research Fund and American
Institute for Cancer Research, 2012). However, as dietary
components are interrelated and may act synergistically, it may
be more informative to investigate the relation of colorectal cancer
with dietary patterns.
The Mediterranean diet (MD) is characterised by a frequent
consumption of vegetables, legumes, fruit and nuts, cereals, fish,
and olive oil as the main seasoning fat; a modest intake of wine,
generally during meals; a low-to-moderate consumption of dairy
products; and a low consumption of meat (Trichopoulou et al,
2000). In terms of nutrients, MD is rich in fibres, antioxidants,
folates, flavonoids, and monounsaturated fats (oleic acid), with
anticarcinogenic activity (La Vecchia et al, 1997; Rossi et al, 2010;
Praud et al, 2014; Rotelli et al, 2015).
A high adherence to the MD has been associated with a reduced
risk of several cancers, including those of the digestive system
(Bosetti et al, 2013; Filomeno et al, 2014; Praud et al, 2014;
Schwingshackl and Hoffmann, 2014). A meta-analysis of five
cohort and two case–control studies reported a statistically
significant 14% reduction of colorectal cancer risk, similar for
cohort and case–control studies (Schwingshackl and Hoffmann,
2014). However, only three studies were conducted in countries
with typical MD: a Greek (Kontou et al, 2012) and an Italian
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(Grosso et al, 2014) case–control studies and an Italian cohort
study (Agnoli et al, 2013), part of the European Prospective
Investigation into Cancer and Nutrition (Bamia et al, 2013).
Thus we assessed the relation between the MD and colorectal
cancer risk in Italy.
MATERIALS AND METHODS
Study population. We pooled data from three hospital-based
case–control studies on colorectal cancer, including a total of 3745
incident, histologically confirmed colorectal cancer cases and 6804
controls. The oldest study, conducted in 1985–91 in Milan,
included 1326 cases (median age 62, range 20–74 years) and 2081
controls (median age 55, range 19–74 years) (La Vecchia et al,
1988); the second study, conducted in 1992–96 in Milan, Genoa,
Pordenone, Gorizia, Forlı`, Latina, and Naples, included 1953 cases
(median age 62, range 19–74 years) and 4154 controls (median age
58, range 19–74 years) (Franceschi et al, 1997); the third study,
conducted in 2008–10 in Milan, Pordenone, and Udine, included
466 cases (median age 67, range 35–80 years) and 569 controls
(median age 66, range 31–80 years). Overall, 488 cases were
cancers of the proximal colon (appendix, caecum, ascending colon,
hepatic flexure, transverse colon), 1078 of the distal colon (splenic
flexure, descending, sigmoid colon), 788 of overlapping or not
otherwise specified colon, 1383 of rectum (rectum and rectosig-
moid junction), and 8 of not otherwise specified colorectum.
Controls were subjects who had not recently changed their diet and
had been admitted to the same hospitals as cases for a wide
spectrum of acute, non-neoplastic conditions unrelated to known
colorectal cancer risk factors (28% traumas, 24% other orthopedic
disorders, 23% surgical conditions, 12% eye diseases, 12% other
illnesses).
Patients were interviewed in hospital by trained interviewers,
using structured questionnaires collecting information on socio-
demographic factors, lifestyle habits (including smoking and
alcohol drinking), anthropometric measures, physical activity,
medical history, and family history of cancer. Information on
patients’ usual diet in the 2 years before diagnosis/interview was
assessed through food frequency questionnaires, collecting infor-
mation on weekly consumption of 29 foods in the first study
(D’Avanzo et al, 1997), and 78 or 56 foods, respectively, in the
other two studies, (Franceschi et al, 1993). Occasional intake (1–3
times per month) was coded as 0.5 per week. The questionnaire of
the first study was tested for reproducibility (D’Avanzo et al, 1997),
and those of the other two studies for reproducibility (Franceschi
et al, 1993; Franceschi et al, 1995; Pearson’s correlation coefficients
for most foods 60–80%) and validity (Decarli et al, 1996; subjects
correctly classified within one quintile of nutrients were 73%).
Intake of nutrients and total energy were computed using Italian
food composition databases (Gnagnarella et al, 2004).
The study protocols were approved by the ethical boards, and all
participants signed an informed consent. Refusal to participate was
o5% for either cases or controls.
Supplementary Table S1 gives the distribution of cases and
controls according to main characteristics.
Mediterranean Diet Score (MDS). Adherence to the traditional
MD was assessed through an a priori defined score
(Trichopoulou et al, 2003), based on nine dietary components.
For components frequently consumed in the MD (vegetables,
legumes, fruit/nuts, cereals, fish/seafood, and a high mono-
unsaturated to saturated fat ratio), participants with consump-
tion above or equal to the study- and sex-specific median value
among controls were assigned a value of 1 and 0 otherwise. For
components less frequently consumed in the MD (dairy and
meat/meat products), participants with consumption above or
equal to the median value were assigned a value of 0 and 1
otherwise. For alcohol, a value of 1 was assigned to moderate
drinkers (drinking below the study- and sex-specific median
intake) and a value of 0 to non-drinkers and drinkers with an
intake above the median values. Supplementary Table S2 shows
the study- and sex-specific median values of each component of
the MD among controls. The MDS was calculated for each
subject by adding up the points for each of the nine components
and ranged between 0 (lowest adherence) and 9 (highest
adherence).
Statistical analysis. Odds ratios (ORs) of colorectal cancer and
the corresponding 95% confidence intervals (CIs) were esti-
mated through unconditional logistic regression models, includ-
ing categorical terms for age, sex, calendar period, centre,
education, body mass index, occupational physical activity,
family history of intestinal cancer, and study-specific total
energy intake. Further adjustment for smoking did not change
ORs. The few missing values for adjusting covariates were
imputed as median values, but the risk estimates did not change
when missing values were considered as indicators or when
we restricted the analyses to the individuals with complete
data only. Tests for linear trend were based on the likelihood-
ratio test between the models with and without a linear term
for the score.
RESULTS
High vs low consumption of vegetables (OR 0.69, 95% CI 0.63–
0.75), legumes (OR 0.69, 95% CI 0.64–0.76), fruit and nuts (OR
0.79, 95% CI 0.73–0.87), fish (OR 0.78, 95% CI 0.71–0.85),
monounsaturated to saturated fatty acid ratio (OR 0.87, 95% CI
0.80–0.95), and low vs high consumption of meat (OR 0.86, 95% CI
0.79–0.94) were associated with a significantly reduced risk of
colorectal cancer. Alcohol intake was not related (OR 1.06, 95% CI
0.96–1.18), and high vs low intake of cereals/potatoes (OR 1.12,
95% CI 1.02–1.24) and low vs high intake of milk/dairy products
(OR 1.09, 95% CI 1.00–1.19) significantly increased colorectal
cancer risk (Table 1).
Table 1. Odds ratios (ORs) and 95% confidence intervals (CIs)
of colorectal cancer among 3745 cases and 6804 controls
according to single components of the Mediterranean Diet
Score (MDS): Italy, 1985–2010
Components of the MDS
Comparison
levela ORb (95% CI)
Vegetables High vs low 0.69 (0.63–0.75)
Legumes High vs low 0.69 (0.64–0.76)
Fruit and nuts High vs low 0.79 (0.73–0.87)
Cereals and potatoes High vs low 1.12 (1.02–1.24)
Fish High vs low 0.78 (0.71–0.85)
Monounsaturated to saturated
fatty acid ratio
High vs low 0.87 (0.80–0.95)
Alcohol Moderate vs
high/non-drinking
1.06 (0.96–1.18)
Meat and meat products Low vs high 0.86 (0.79–0.94)
Milk and dairy products Low vs high 1.09 (1.00–1.19)
aHigh: consumption above or equal to the study- and sex-specific median value; low:
consumption below the study- and sex-specific median value; moderate: consumption
higher than zero but below or equal to the study- and sex-specific median value.
bEstimated from logistic regression models adjusted for age, sex, calendar period, centre,
education, body mass index, occupational physical activity, family history of intestinal
cancer, and total energy intake.
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Compared with a 0–2 MDS (lowest adherence), the OR was 0.52
(95% CI 0.43–0.62) for a 7–9 MDS (highest adherence), with a
significant strong inverse trend in risk (Table 2). The OR for a
1-point increment in the MDS was 0.89 (95% CI 0.86–0.91). The
corresponding ORs excluding in turn each of the nine components
(sensitivity analysis) ranged from 0.87 (95% CI 0.84–0.89) to 0.92
(95% CI 0.89–0.94).
The inverse relation was consistent across strata of age, sex,
education, body mass index, physical activity, energy intake, and
history of intestinal cancer in first-degree relatives (Supplementary
Table S3).
The OR for a 1-point increment in the MSD was 0.90 (95% CI
0.85–0.96) for proximal colon, 0.88 (95% CI 0.84–0.92) for distal
colon, 0.85 (95% CI 0.81–0.89) for overlapping and undefined colon,
and 0.90 (95% CI 0.86–0.93) for rectal cancer (Table 3).
DISCUSSION
Combining the three Italian studies, the highest adherence to the
MD compared with the lowest reduced colorectal cancer risk by
about 50%, consistent across the large bowel. We found a stronger
inverse association between MD and colorectal cancer than that
reported in a Greek case–control study (OR 0.88; Kontou et al,
2012) but similar to that found in an Italian case–control study
(OR 0.46; Grosso et al, 2014) and an Italian cohort study (hazard
ratio 0.50; Agnoli et al, 2013) and stronger than that found in a
meta-analysis (pooled relative risk of 0.86; Schwingshackl and
Hoffmann, 2014). However, comparison between studies is
difficult because of the differences of dietary habits between
various countries, the use of different components and cut points
Table 2. Odds ratios (ORs) and 95% confidence intervals (CIs) of colorectal cancer among 3745 cases and 6804 controls
according to the Mediterranean Diet Score (MDS): Italy, 1985–2010
Cases Controls
No. of MDS
components No.a % No.a % ORb (95% CI)
0–2 529 14.1 736 10.8 1c
3 662 17.7 1112 16.4 0.79 (0.68–0.92)
4 910 24.3 1551 22.8 0.76 (0.65–0.87)
5 792 21.2 1573 23.2 0.63 (0.54–0.73)
6 528 14.1 1103 16.2 0.58 (0.49–0.68)
7–9 318 8.5 717 10.6 0.52 (0.43–0.62)
P-value for trend o0.0001
1-point increment 0.89 (0.86–0.91)
aThe sum does not add up to the total because of 18 missing values (6 cases and 12 controls) on a few MDS components (i.e., monounsaturated to saturated fatty acid ratio, alcohol, and
legumes).
bEstimated from logistic regression models adjusted for age, sex, calendar period, centre, education, body mass index, occupational physical activity, family history of intestinal cancer, and
total energy intake.
cReference category.
Table 3. Distribution of subsite-specific colorectal cancer cases and of controls and corresponding odds ratios (ORs) and 95%
confidence intervals (CIs), according to the Mediterranean Diet Score (MDS): Italy, 1985–2010
Controls Colon cancer
(overall)
Proximal colon
cancera
Distal colon
cancera
Overlapping and
undefined colon
cancera
Rectal
cancera
No. of MDS
components No.b No.b ORc (95% CI) No.b ORc (95% CI) No.b ORc (95% CI) No.b ORc (95% CI) No.b ORc (95% CI)
Overall 6804 2354 488 1078 788 1383
0–2 736 351 1d 79 1d 145 1d 127 1d 177 1d
3 1112 397 0.71 (0.59–0.85) 70 0.55 (0.39–0.78) 197 0.85 (0.67–1.08) 130 0.62 (0.47–0.82) 265 0.94 (0.76–1.17)
4 1551 587 0.73 (0.61–0.86) 113 0.63 (0.46–0.86) 276 0.84 (0.67–1.05) 198 0.64 (0.50–0.83) 320 0.81 (0.65–0.99)
5 1573 485 0.57 (0.48–0.67) 107 0.56 (0.41–0.77) 215 0.60 (0.48–0.77) 163 0.50 (0.39–0.65) 305 0.73 (0.59–0.91)
6 1103 328 0.53 (0.44–0.64) 75 0.54 (0.38–0.76) 148 0.58 (0.45–0.75) 105 0.45 (0.33–0.60) 199 0.67 (0.53–0.85)
7–9 717 202 0.49 (0.39–0.60) 43 0.48 (0.32–0.73) 95 0.55 (0.41–0.74) 64 0.39 (0.28–0.54) 115 0.58 (0.44–0.75)
P-value for trend o0.0001 0.001 o0.0001 o0.0001 o0.0001
1-point increment 0.88 (0.85–0.91) 0.90 (0.85–0.96) 0.88 (0.84–0.92) 0.85 (0.81–0.89) 0.90 (0.86–0.93)
aProximal colon (International Classification of Diseases, vol. 10, ICD-10, C18.0–C18.4), distal colon (ICD-10, C18.5–C18.7), overlapping and undefined colon (ICD-10, C18.8–C18.9) and rectal
(ICD-10, C19.9–C20.9) cancer.
bThe sum does not add up to the total because of some missing values on a few MDS components (i.e. monounsaturated to saturated fatty acid ratio, alcohol, and legumes).
cEstimated from logistic regression models adjusted for age, sex, calendar period, centre, education, body mass index, occupational physical activity, family history of intestinal cancer, and
total energy intake.
dReference category.
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in the MD definition, and the different prevalence of adherence to
the MD. The MDS is based on the median consumption among the
control group within the study population, and not in absolute
terms, and subjects with a higher MDS in this Italian population
are likely to have a higher absolute consumption of foods that are
typical of the MD.
Limitations of this study include pooling results from studies
with different food frequency questionnaire and possible selection
and information bias. However, cases and controls were inter-
viewed in the same hospital setting, had similar very high
participation rate, and were from comparable catchment area.
We excluded from the controls patients admitted for conditions
related to known risk factors for colorectal cancer and those with
long-term dietary modifications. The strengths of the study include
the use of food frequency questionnaires with satisfactory
reproducibility (D’Avanzo et al, 1997; Franceschi et al, 1997) and
validity (Decarli et al, 1996). Our estimates were adjusted for major
confounding variables, and the consistency of the associations
across strata of major covariates rules out a major role of residual
confounding. Another strength of our study is the large sample
size, based on 43700 cases, and the study population with an
overall high adherence to MD, allowing for the investigation of
high absolute amounts of foods typical of this diet.
Thus this large study conducted in a Mediterranean region
confirms a favourable role of MD on colorectal cancer risk.
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